Profund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Profund Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Buy	+41,229	New	+$318K	0.01%	774
2023 Q3	–	Sell	-42,644	Closed	-$281K	–	1087
2023 Q2	$281K	Sell	42,644 -3,041	-7%	-$19.5K	0.02%	764
2023 Q1	$310K	Buy	+45,685	New	+$321K	0.02%	701
2021 Q3	–	Sell	-10,855	Closed	-$231K	–	1449
2021 Q2	$231K	Buy	+10,855	New	+$194K	0.01%	1264
2019 Q1	–	Sell	-15,756	Closed	-$412K	–	1244
2018 Q4	$412K	Sell	15,756 -9,030	-36%	-$212K	0.03%	564
2018 Q3	$569K	Buy	+24,786	New	+$506K	0.02%	705

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Profund Advisors's VNDA Position: Q1 2026 in Review

Profund Advisors opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 41,229 shares worth $285K. The stake represents 0.01% of the portfolio and ranks #774 among its holdings. This is a return to the name: Profund Advisors previously reported a position in VNDA as recently as Q2 2023.

Profund Advisors first reported a position in VNDA in Q3 2018 and has held it in 6 quarters since. The position peaked at $569K in Q3 2018. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Profund Advisors held 41,229 shares of Vanda Pharmaceuticals worth $285K as of Q1 2026.
Vanda Pharmaceuticals was a new Profund Advisors position in Q1 2026.
Vanda Pharmaceuticals made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #774 holding.
Profund Advisors first reported a position in Vanda Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
Profund Advisors's Vanda Pharmaceuticals position peaked at $569K in Q3 2018.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.